Literature DB >> 29293244

Cancer immunotherapy.

Eric Bender.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29293244     DOI: 10.1038/d41586-017-08699-z

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Mechanisms of tumor immunotherapy, with a focus on thoracic cancers.

Authors:  Simona Ferro; Veronica Huber; Licia Rivoltini
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Vitamin A deficiency execrates Lewis lung carcinoma via induction of type 2 innate lymphoid cells and alternatively activates macrophages.

Authors:  Weiwei Cui; Wenxin Zhang; Xiaofeng Yuan; Shanshan Liu; Meng Li; Junqi Niu; Peng Zhang; Dong Li
Journal:  Food Sci Nutr       Date:  2019-02-10       Impact factor: 2.863

3.  Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.

Authors:  Yaohui Gao; Dexi Bi; Ruting Xie; Man Li; Jing Guo; Hu Liu; Xianling Guo; Juemin Fang; Tingting Ding; Huiyuan Zhu; Yuan Cao; Meichun Xing; Jiayi Zheng; Qing Xu; Qian Xu; Qing Wei; Huanlong Qin
Journal:  Signal Transduct Target Ther       Date:  2021-11-19

Review 4.  Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.

Authors:  Dong-Rui Wang; Xian-Lin Wu; Ying-Li Sun
Journal:  Signal Transduct Target Ther       Date:  2022-09-19

5.  PD-1-siRNA Delivered by Attenuated Salmonella Enhances the Antitumor Effect of Chloroquine in Colon Cancer.

Authors:  Shuya Lu; Jianhui Gao; Huijie Jia; Yang Li; Yongbin Duan; Fuyang Song; Zhiang Liu; Shuai Ma; Mingyong Wang; Tiesuo Zhao; Jiateng Zhong
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.